Geron to Present at the Needham Healthcare Conference

MENLO PARK, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the 17th Annual Needham Healthcare Conference in New York at 4:00 p.m. Eastern Time on Tuesday, March 27, 2018.

A live webcast of the presentation will be available through the Investor Relations pages of Geron’s website and at http://wsw.com/webcast/needham86/gern/. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.Investor and Media Relations650-473-7765[email protected][email protected]

You May Also Be Interested In

• BNY Announces Intention to Increase Quarterly Common Stock Dividend by 19 Percent to $0.63 per Share
• Compass Working Capital Celebrates Passage of Pilot Program to Strengthen Asset-Building Initiative in Bipartisan Housing Bill
• Black Hills Corp. Releases 2025 Corporate Sustainability Report Highlighting Continued Progress on Goals and Customer-focused Solutions